Back to search

Article

Anaplastic thyroid carcinoma in Argentina: real-world diagnostic lags and treatment barriers

2026-05-21

Abstract excerpt

<title>Abstract</title> <p> Purpose Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy with high mortality. Approximately 50% harbor the <italic>BRAF V600E</italic> mutation, for which dabrafenib-trametinib (DT) improves survival (OS). Prompt diagnosis and access to molecular testing and targeted therapy are critical for outcomes. We evaluated diagnostic and therapeutic barriers in ATC patients tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa2e3584-bf75-5429-9895-1fdcf0b55ab0
DOI
10.21203/rs.3.rs-9462781/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anaplastic thyroid carcinoma in Argentina: real-world diagnostic lags and treatment barriersDOI 10.21203/rs.3.rs-9462781/v1
Untitled literature recordSemantic proximity
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.Semantic proximity
Dramatic clinical response to dabrafenib plus trametinib in anaplastic thyroid carcinoma and the challenges faced during the COVID-19 pandemic.Semantic proximity
Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.Semantic proximity
A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancerSemantic proximity
Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck Cancer Groups.Semantic proximity
Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.Semantic proximity
Mutation based approaches to the treatment of anaplastic thyroid cancer.Semantic proximity
Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience.Semantic proximity
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.Semantic proximity
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease.Semantic proximity
Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study.Semantic proximity
Select a neighboring publication to make it the new centre.